These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8937669)

  • 21. [Curative treatment of invasive aspergillosis].
    Dupont B
    Pathol Biol (Paris); 1994 Sep; 42(7):688-93. PubMed ID: 7877863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flucytosine.
    Bennet JE
    Ann Intern Med; 1977 Mar; 86(3):319-21. PubMed ID: 320931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of cryptococcal meningitis with five anti-fungal drugs: the role of amphotericin B.
    Shindo K
    Drugs Exp Clin Res; 1990; 16(7):327-32. PubMed ID: 1965500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii.
    Chen SC; Korman TM; Slavin MA; Marriott D; Byth K; Bak N; Currie BJ; Hajkowicz K; Heath CH; Kidd S; McBride WJ; Meyer W; Murray R; Playford EG; Sorrell TC;
    Clin Infect Dis; 2013 Aug; 57(4):543-51. PubMed ID: 23697747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic antifungal drugs.
    Med Lett Drugs Ther; 1996 Feb; 38(967):10-2. PubMed ID: 8559113
    [No Abstract]   [Full Text] [Related]  

  • 26. Amphotericin B with or without flucytosine followed by fluconazole as primary therapy for cryptococcal meningitis in patients with AIDS.
    Jaruratanasirikul S
    Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):719-23. PubMed ID: 9253873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of fluconazole singly and in combination with 5-fluorocytosine or amphotericin B in the treatment of cryptococcal meningoencephalitis in an intracranial murine model.
    Hossain MA; Mukherjee PK; Reyes G; Long L; Ghannoum MA
    J Chemother; 2002 Aug; 14(4):351-60. PubMed ID: 12420852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluconazole-resistant Cryptococcus neoformans isolated from an immunocompetent patient without prior exposure to fluconazole.
    Orni-Wasserlauf R; Izkhakov E; Siegman-Igra Y; Bash E; Polacheck I; Giladi M
    Clin Infect Dis; 1999 Dec; 29(6):1592-3. PubMed ID: 10585832
    [No Abstract]   [Full Text] [Related]  

  • 29. Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis.
    Dannaoui E; Abdul M; Arpin M; Michel-Nguyen A; Piens MA; Favel A; Lortholary O; Dromer F;
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2464-70. PubMed ID: 16801427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Itraconazole and flucytosine+itraconazole combination in the treatment of experimental cryptococcosis in hamsters.
    Iovannitti C; Negroni R; Bava J; Finquelievich J; Kral M
    Mycoses; 1995; 38(11-12):449-52. PubMed ID: 8720194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current approach to the acute management of cryptococcal infections.
    Powderly WG
    J Infect; 2000 Jul; 41(1):18-22. PubMed ID: 11041709
    [No Abstract]   [Full Text] [Related]  

  • 32. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.
    Saag MS; Graybill RJ; Larsen RA; Pappas PG; Perfect JR; Powderly WG; Sobel JD; Dismukes WE
    Clin Infect Dis; 2000 Apr; 30(4):710-8. PubMed ID: 10770733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination therapy in experimental invasive aspergillosis.
    George D; Kordick D; Miniter P; Patterson TF; Andriole VT
    J Infect Dis; 1993 Sep; 168(3):692-8. PubMed ID: 8354911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluconazole alone or combined with flucytosine for the treatment of AIDS-associated cryptococcal meningitis.
    Milefchik E; Leal MA; Haubrich R; Bozzette SA; Tilles JG; Leedom JM; McCutchan JA; Larsen RA
    Med Mycol; 2008 Jun; 46(4):393-5. PubMed ID: 18415850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of cryptococcosis in patients with acquired immunodeficiency syndrome].
    Graybill JR
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():26-30. PubMed ID: 9441302
    [No Abstract]   [Full Text] [Related]  

  • 36. Poor efficacy of amphotericin B-based therapy in CNS aspergillosis.
    Schwartz S; Ruhnke M; Ribaud P; Reed E; Troke P; Thiel E
    Mycoses; 2007 May; 50(3):196-200. PubMed ID: 17472616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First report of Cryptococcus laurentii meningitis and a fatal case of Cryptococcus albidus cryptococcaemia in AIDS patients.
    Kordossis T; Avlami A; Velegraki A; Stefanou I; Georgakopoulos G; Papalambrou C; Legakis NJ
    Med Mycol; 1998 Oct; 36(5):335-9. PubMed ID: 10075504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.
    Friese G; Discher T; Füssle R; Schmalreck A; Lohmeyer J
    AIDS; 2001 Nov; 15(17):2344-5. PubMed ID: 11698718
    [No Abstract]   [Full Text] [Related]  

  • 39. Cryptococcal cellulitis in an immunocompetent host.
    Sanchez-Albisua B; Rodriguez-Peralto JL; Romero G; Alonso J; Vanaclocha F; Iglesias L
    J Am Acad Dermatol; 1997 Jan; 36(1):109-12. PubMed ID: 8996275
    [No Abstract]   [Full Text] [Related]  

  • 40. Discontinuation of secondary prophylaxis against cryptococcosis in patients with AIDS receiving highly active antiretroviral therapy.
    Rollot F; Bossi P; Tubiana R; Caumes E; Zeller V; Katlama C; Bricaire F
    AIDS; 2001 Jul; 15(11):1448-9. PubMed ID: 11504971
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.